Epidemiology of preeclampsia
Main Article Content
Preeclampsia is a major contributor to maternal mortality, premature birth, intrauterine growth retardation, and perinatal mortality. The exact causes of preeclampsia are unknown, but several epidemiological factors and specific clinical changes in the second trimester of pregnancy have been associated with the disease. This paper briefly reviews epidemiological, immunogenetic, and biochemical factors related to the prevention of the most common and serious pregnancy complications.
- Epidemiología
- preeclamsia
- mortalidad materna
- parto prematuro
Gudson, JP, Anderson, SG & May, WJ. A clinical evaluation of the roll-over test for pregnancy-induced hypertension. Am J Obst Gynecol, 1977, 127: 1-3. DOI: https://doi.org/10.1016/0002-9378(77)90304-0
Ministerio de Salud, República de Colombia. ProgramaMaterno Infantil: Hechos y proyecciones. 3ª ed. Bogotá, 1987.
Saa Barona, O. Causas de mortalidad neonatal en la Unidad Regional de Occidente, Guapi. Tesis Magíster en Epidemiología, Departamento Medi-cina Social, Universidad del Valle, 1987.
Mier-Teran, M. Sorne aspects of interrelationship between fertility patterns and health. World Health Stat Q, 1987, 40: 41-53.
Need, JA. Fenómenos inmunológicos en toxemia preeclámptica. Clin Obst Gynecol, 1979, 3: 443-460. DOI: https://doi.org/10.1016/S0306-3356(21)00481-7
MacGillivray, l. Some observations on the incidence of preeclampsia. J Obstet Gynaecol Br Commonwealth, 1958, 65: 536-539. DOI: https://doi.org/10.1111/j.1471-0528.1958.tb08557.x
Klonoff-Cohen, HS, Savits, DA, & Cefalo, RE. An epidemiologic study of contraception and preeclampsia.JAMA, 1984, 262: 3143-3147. DOI: https://doi.org/10.1001/jama.262.22.3143
Scott JR, Beer, AE & Stastny, P. Immunogenetic factors in preeclampsia and eclampsia. JAMA, 1976, 235: 402-404. DOI: https://doi.org/10.1001/jama.235.4.402
Hoff, C, Peevy K, & Giathina, K. Maternal-fetal HLA-DRrelationships. Obst Gynecol, 1992, 80: 1007-1012.
Goodman, HS & Masaits, L. Analysis of the immune response to leuko-cytes l. Maternal cytotoxic response to fetal lymphocytes. Proc Soc Exp Biol Med, 1967, 126: 599-604. DOI: https://doi.org/10.3181/00379727-126-32517
Stevenson, AC. Contribution of fetal-maternal incompatibility to etiology of preeclamptic toxemia. Lancet, 1971, 2: 1286-1289. DOI: https://doi.org/10.1016/S0140-6736(71)90604-0
Fingleton, AM. Leucocytotoxic antibodies and preeclamptic toxemia of pregnancy. Transplantation, 1971, 12: 319-321. DOI: https://doi.org/10.1097/00007890-197110000-00015
Boss, JH. Antigenic relationship between placenta of kidneys in humans. Am J Obstet Gynecol, 1965, 93: 574-582. DOI: https://doi.org/10.1016/0002-9378(65)90519-3
Langford,HG,DouglasBH&Arhelger, RB. A model of preeclampsia: l. Blood pressure changes produced by antiplacental serum. Johns Hopkins MedJ, 1967, 120: 220-224.
Ylikorkala, O, & Makila, UM. Prostacyclin and thromboxane in gynecology and obstetrics. AmJ Obstet Gynecol, 1985, 152: 318-329. DOI: https://doi.org/10.1016/S0002-9378(85)80221-0
Makila, UM, Jouppila, P, Kirkinen, N. et al. Relation between umbilical prostacyclin production and blood flow in fetus. Lancet, 1983, 1: 728-732. DOI: https://doi.org/10.1016/S0140-6736(83)92024-X
Makila, UM, Viinikka, L& Ylilorkala, O. Increased thromboxane A2 production but normal prostacyclin by the placenta in hypertensive pregnancies. Prostaglandins, 1984, 27: 87-95. DOI: https://doi.org/10.1016/0090-6980(84)90222-3
Stuart MJ, Sunderji, SG. Yambo, T. et al. Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet, 1981, 1: 11126-1128.
Goodman, RP, Killan, AP & Brash, AR. Prostacyclin production during pregnancy complicated by hypertension. Am J Obstet Gynecol, 1982, 142: 817-822. DOI: https://doi.org/10.1016/S0002-9378(16)32525-X
Bussolino, F, Benedetto, G.,Massobrio, M. et al. Maternal vascular prostacyclin activity in preeclampsia. Lancet, 1980, 2: 702. DOI: https://doi.org/10.1016/S0140-6736(80)92746-4
Brown, JJ, Davies, PB, Doak, A. Fetal plasma renin concentration in hypertensive disease of pregnancy. J Obstet Gynaecol Br Commonwealth, 1966, 73: 410-414. DOI: https://doi.org/10.1111/j.1471-0528.1966.tb05181.x
Brown, JJ, Davies, PB, Doak, AF et al. Plasma renin concentration in hypertensive disease of pregnancy. Lancet, 1965, 2: 1219. DOI: https://doi.org/10.1136/bmj.2.5472.1215
Davidge, ST, Hu bel, CA, & Brayden, RD. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol, 1992, 79: 897-901.
Roberts, JM, Taylor, RN & Musci, TJ. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol, 1989, 161: 1200-1204. DOI: https://doi.org/10.1016/0002-9378(89)90665-0
Hubel, CA, Roberts, JM & Taylor, RN. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol, 1989,161: 1025-1034. DOI: https://doi.org/10.1016/0002-9378(89)90778-3
Rippman, ET. Psychosomatic EPH gestosis. Pp. 767-772.JnEmotionsand reproduction. Carenza, L & Zichella, L (eds). Academic Press, London, 1979.
Muller-Tyl & Wimmer-Puchinger, BP. Psychosomatic aspects of toxemia. J Psychosom Obstet Gynecol, 1982, 1: 111-117. DOI: https://doi.org/10.3109/01674828209081239
Hetzel, BS, Bruer, B & Poidevedu, LS.A survey of the relation between certain common antenatal complications in primiparae and stressful life situations during pregnancy. i Psychosom Res, 1961,5: 175-182. DOI: https://doi.org/10.1016/0022-3999(61)90044-7
Herrera, JA, Al varado, JP & Martínez, JE. Toe psychosocial environment and the cellular immunity in the pregnant patient. Stress Med, 1988, 4: 2-IO. DOI: https://doi.org/10.1002/smi.2460040109
Newman, V & Pulleston, JJ. Role of nutrition in the prevention of preeclampsia.i Nurse-Midwifery, 1990, 35: 282-291. DOI: https://doi.org/10.1016/0091-2182(90)90081-F
Gant, NPS & Wonley, RJ. A clinical test useful for predicting the development of acute hypertension in pregnancy. Ami Obstet Gynecol, 1974, 120: 1-IO DOI: https://doi.org/10.1016/0002-9378(74)90170-7
O'Brien, WP. Predicting preeclampsia. Obstet Gynecol, 1990, 75: 445-450.
Burton, AC. Physiology and biophysics of the circulation. Year Book, Chicago, 1965
Repke, JT & Villar, J. Pregnancy-induced hypertension and low birth weight: the role of calcium. Ami Clin Nutr, 1991, 54: 237S. DOI: https://doi.org/10.1093/ajcn/54.1.237S
Belizán, JM, Vi llar, J, Salazar, A, etal. Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. Ami Obstet Gynecol, 1983, 146: 175-180. DOI: https://doi.org/10.1016/0002-9378(83)91049-9
Repke, JT. Calcium, magnesium, and zinc supplementation and perinatal outcome. Clin Obstet Gynecol, 1991, 34: 262. DOI: https://doi.org/10.1097/00003081-199106000-00006
Olsen, SP, & Secher, NJ. A possible effect of low-dose fish oil on early delivery and preeclampsia. Indications from a50-year-old controlled tria!. Br i Nutr, 1990, 64: 599-609. DOI: https://doi.org/10.1079/BJN19900063
Laivuori, H, Hovatta, O, Viinikka, L, et al. Dietary supplementation with primrose oíl or fish oíl does not change urinary excretion of prostacyclin and thromboxane metabolites in pre-eclamptic women. Prostaglandins, 1993, 49: 691-694. DOI: https://doi.org/10.1016/0952-3278(93)90079-C
Conradt, A. Pathophysiology and clinical aspects of preeclampsia. Z Geburtshilfe Perinatol, 1985, 189: 149-161.
Sibai, BM, Villar, MA & Bray, E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am Obstet Gynecol, 1989, 161: 115-159. DOI: https://doi.org/10.1016/0002-9378(89)90246-9
Moodley, J & Norman, RJ. Attempts at dietary alteration of prostaglandin pathways in the management of preeclampsia. Prostaglandins, 1989, 37: 145-147. DOI: https://doi.org/10.1016/0952-3278(89)90077-X
D'Almeida, A, Carter, JP. & Anatol, A. Effects of a combination of evening primrose oil and fish oil versus magnesium and placebo in preventing preeclampsia. WomHealth, 1992, 19: 117-131. DOI: https://doi.org/10.1300/J013v19n02_07
Herrera, JA. Nutritional factors and rest reduce pregnancy-induced hypertension and preeclampsia in positive roll-overtest primigravids. /nt i Gynecol Obstet, 1993, 41: 31-35. DOI: https://doi.org/10.1016/0020-7292(93)90151-L
Beaufils, M, Donsimoni, R, Uzan, S. et al. Prevention of preeclampsia by early antiplatelet therapy. Lancet, 1985, 1: 840-842. DOI: https://doi.org/10.1016/S0140-6736(85)92207-X
-842.
Wallenburg, HCS, Makocvitz, JW & Dekker, GA. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet, 1986, 1: 1-3. DOI: https://doi.org/10.1016/S0140-6736(86)91891-X
Schiff, E, Barkai, G, Ben-Baruch, G. et al. Low-dose aspirin does not influence the clinical course of women with rare pregnancy-induced hypertension. Obstet Gynecol, 1990, 76: 742-744. DOI: https://doi.org/10.1097/00006250-199011000-00002
Imperiale, TP & Petrulis, AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease.JAMA, 1991,266: 260-264. DOI: https://doi.org/10.1001/jama.266.2.260
López, M. Calcio y aspirina para la prevención de la hipertensión arterial inducida por el embarazo. Análisis y metaanálisis de investigaciones clínicas aleatorias. Libro de resúmenes. Resumen 1154. N Congreso Argentino de Perinatología, Buenos Aires, Argentina, 1992.
Belizán, JM. Prevention of hypertensive disorders of pregnancy with calcium supplementation. P. 93. lnProceedings. 8th World Congress on hypertension in pregnancy. Buenos Aires, 1992.
Roth, GJ, Stanford, N, Majerus, PW. Acetylation of prostaglandin synthetase by aspirine. Proc Natl Acad Sci USA, 1975, 72: 3073-3076. DOI: https://doi.org/10.1073/pnas.72.8.3073
Stuart, MJ, Gross, SJ, Elrad, H., et al. Effects of acetylsalicylic-acid ingestion on maternal and neonatal hemostasis. N Engll Med, 1982, 307: 909-911. DOI: https://doi.org/10.1056/NEJM198210073071502
Downloads
- Arnoldo Bromet S., Julián A. Herrera M., Evaluación de los modelos de atención en el cuidado primario en salud , Colombia Medica: Vol. 25 No. 1 (1994)
- Alvaro I. Correa, Julián A. Herrera M., The extended family and the family function , Colombia Medica: Vol. 24 No. 4 (1993)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use